We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 118

Supreme Court clarifies basis for liability under the False Claims Act
  • Bricker & Eckler LLP
  • USA
  • June 16 2016

On June 16, 2016, the U.S. Supreme Court issued its ruling in Universal Health Services, Inc. v. United States ex rel. Escobar. The case involves


United States House of Representatives v. Burwell: An uncertain future for cost-sharing subsidies
  • Bricker & Eckler LLP
  • USA
  • May 17 2016

On May 12, 2016, the United States District Court for the District of Columbia issued a decision in United States House of Representatives v. Burwell


Ohio Supreme Court rules that patient medical record not defined by what is kept by hospital’s medical records department
  • Bricker & Eckler LLP
  • USA
  • March 24 2016

In a 5-2 decision on March 23, 2016, the Supreme Court of Ohio ruled that under state law, a patient’s medical record consists of all data that is


U.S. Supreme Court deals a blow to all payer claims databases
  • Bricker & Eckler LLP
  • USA
  • March 2 2016

All payer claims databases, which have been set up in 20 states and are seemingly an invaluable and inevitable tool in many payment reform


False Claims Act: 2015 year in review and 2016 look ahead
  • Bricker & Eckler LLP
  • USA
  • February 15 2016

On December 3, 2015, the Department of Justice (DOJ) announced that it recovered more than $3.5 billion in settlements and judgments from civil cases


UPDATE: 4,000 percent increase in drug price, capitalism and fiduciary duty
  • Bricker & Eckler LLP
  • USA
  • December 17 2015

As we discussed in September, Martin Shkreli garnered a lot of unwanted attention when declaring that his company, Turing Pharmaceuticals AG, would


Tuomey case closed!
  • Bricker & Eckler LLP
  • USA
  • October 22 2015

The saga of the Tuomey case has finally come to an end. After 10 long years of investigation, litigation and appeals, on October 16, 2015, the


4,000 percent increase in drug price, capitalism and fiduciary duties
  • Bricker & Eckler LLP
  • USA
  • September 23 2015

It recently came to light that after acquiring the exclusive rights to market a drug known as Daraprim, which is used to combat toxoplasmosis, Turing


Department of Justice wins federal court ruling on 60-day overpayment rule
  • Bricker & Eckler LLP
  • USA
  • August 7 2015

On August 3, 2015, a federal court issued the first court opinion interpreting the False Claims Act's (FCA) 60-day overpayment rule since it was


$237 million judgment against Tuomey Healthcare upheld by federal appeals court
  • Bricker & Eckler LLP
  • USA
  • July 7 2015

On July 2, the U.S. Circuit Court of Appeals for the Fourth Circuit upheld the $237 million judgment against Tuomey Healthcare System located in